<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d12" origId="Daptomycin"><sentence id="DrugDDI.d12.s0" origId="s0" text="Warfarin Concomitant administration of daptomycin (6 mg/kg once every 24 hours for 5 days) and warfarin (25 mg single oral dose) had no significant effect on the pharmacokinetics of either drug, and the INR was not significantly altered."><entity charOffset="0-8" id="DrugDDI.d12.s0.e0" origId="s0.p0" text="Warfarin" type="drug"/><entity charOffset="39-49" id="DrugDDI.d12.s0.e1" origId="s0.p1" text="daptomycin" type="drug"/><entity charOffset="95-103" id="DrugDDI.d12.s0.e2" origId="s0.p9" text="warfarin" type="drug"/><entity charOffset="189-193" id="DrugDDI.d12.s0.e3" origId="s0.p18" text="drug" type="drug"/><pair e1="DrugDDI.d12.s0.e0" e2="DrugDDI.d12.s0.e1" id="DrugDDI.d12.s0.p0" interaction="false"/><pair e1="DrugDDI.d12.s0.e0" e2="DrugDDI.d12.s0.e2" id="DrugDDI.d12.s0.p1" interaction="false"/><pair e1="DrugDDI.d12.s0.e0" e2="DrugDDI.d12.s0.e3" id="DrugDDI.d12.s0.p2" interaction="false"/><pair e1="DrugDDI.d12.s0.e1" e2="DrugDDI.d12.s0.e2" id="DrugDDI.d12.s0.p3" interaction="false"/><pair e1="DrugDDI.d12.s0.e1" e2="DrugDDI.d12.s0.e3" id="DrugDDI.d12.s0.p4" interaction="false"/><pair e1="DrugDDI.d12.s0.e2" e2="DrugDDI.d12.s0.e3" id="DrugDDI.d12.s0.p5" interaction="false"/><negationtags>Warfarin Concomitant administration of daptomycin (6 mg/kg once every 24 hours for 5 days) and warfarin (25 mg single oral dose) had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; significant effect on the pharmacokinetics of either drug&lt;/xcope&gt;, and &lt;xcope&gt;the INR was &lt;cue&gt;not&lt;/cue&gt; significantly altered&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d12.s1" origId="s1" text="As experience with the concomitant administration of daptomycin and warfarin is limited to volunteer studies, anticoagulant activity in patients receiving daptomycin and warfarin should be monitored for the first several days after initiating therapy with Fentanyl."><entity charOffset="53-63" id="DrugDDI.d12.s1.e0" origId="s1.p26" text="daptomycin" type="drug"/><entity charOffset="68-76" id="DrugDDI.d12.s1.e1" origId="s1.p28" text="warfarin" type="drug"/><entity charOffset="155-165" id="DrugDDI.d12.s1.e2" origId="s1.p37" text="daptomycin" type="drug"/><entity charOffset="170-178" id="DrugDDI.d12.s1.e3" origId="s1.p39" text="warfarin" type="drug"/><entity charOffset="256-264" id="DrugDDI.d12.s1.e4" origId="s1.p45" text="Fentanyl" type="drug"/><pair e1="DrugDDI.d12.s1.e0" e2="DrugDDI.d12.s1.e1" id="DrugDDI.d12.s1.p0" interaction="false"/><pair e1="DrugDDI.d12.s1.e0" e2="DrugDDI.d12.s1.e2" id="DrugDDI.d12.s1.p1" interaction="false"/><pair e1="DrugDDI.d12.s1.e0" e2="DrugDDI.d12.s1.e3" id="DrugDDI.d12.s1.p2" interaction="false"/><pair e1="DrugDDI.d12.s1.e0" e2="DrugDDI.d12.s1.e4" id="DrugDDI.d12.s1.p3" interaction="false"/><pair e1="DrugDDI.d12.s1.e1" e2="DrugDDI.d12.s1.e2" id="DrugDDI.d12.s1.p4" interaction="false"/><pair e1="DrugDDI.d12.s1.e1" e2="DrugDDI.d12.s1.e3" id="DrugDDI.d12.s1.p5" interaction="false"/><pair e1="DrugDDI.d12.s1.e1" e2="DrugDDI.d12.s1.e4" id="DrugDDI.d12.s1.p6" interaction="false"/><pair e1="DrugDDI.d12.s1.e2" e2="DrugDDI.d12.s1.e3" id="DrugDDI.d12.s1.p7" interaction="false"/><pair e1="DrugDDI.d12.s1.e2" e2="DrugDDI.d12.s1.e4" id="DrugDDI.d12.s1.p8" interaction="false"/><pair e1="DrugDDI.d12.s1.e3" e2="DrugDDI.d12.s1.e4" id="DrugDDI.d12.s1.p9" interaction="false"/></sentence><sentence id="DrugDDI.d12.s2" origId="s2" text="HMG-CoA Reductase Inhibitors Inhibitors of HMG-CoA reductase may cause myopathy, which is manifested as muscle pain or weakness associated with elevated levels of CPK."><entity charOffset="0-28" id="DrugDDI.d12.s2.e0" origId="s2.p46" text="HMG-CoA Reductase Inhibitors" type="drug"/><entity charOffset="43-60" id="DrugDDI.d12.s2.e1" origId="s2.p47" text="HMG-CoA reductase" type="drug"/><pair e1="DrugDDI.d12.s2.e0" e2="DrugDDI.d12.s2.e1" id="DrugDDI.d12.s2.p0" interaction="false"/></sentence><sentence id="DrugDDI.d12.s3" origId="s3" text="There were no reports of skeletal myopathy in a placebo-controlled Phase I trial in which 10 healthy subjects on stable simvastatin therapy were treated concurrently with daptomycin (4 mg/kg once every 24 hours) for 14 days."><entity charOffset="120-131" id="DrugDDI.d12.s3.e0" origId="s3.p66" text="simvastatin" type="drug"/><entity charOffset="171-181" id="DrugDDI.d12.s3.e1" origId="s3.p70" text="daptomycin" type="drug"/><pair e1="DrugDDI.d12.s3.e0" e2="DrugDDI.d12.s3.e1" id="DrugDDI.d12.s3.p0" interaction="false"/><negationtags>There were &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; reports of skeletal myopathy in a placebo-controlled Phase I trial in which 10 healthy subjects on stable simvastatin therapy were treated concurrently with daptomycin (4 mg/kg once every 24 hours) for 14 days&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d12.s4" origId="s4" text="Experience with co-administration of HMG-CoA reduc-tase inhibitors and Fentanyl in patients is limited,therefore,consideration should be given to temporarily suspending use of HMG-CoA reductase inhibitors in patients receiving Fentanyl."><entity charOffset="37-44" id="DrugDDI.d12.s4.e0" origId="s4.p79" text="HMG-CoA" type="drug"/><entity charOffset="71-79" id="DrugDDI.d12.s4.e1" origId="s4.p81" text="Fentanyl" type="drug"/><entity charOffset="176-204" id="DrugDDI.d12.s4.e2" origId="s4.p94" text="HMG-CoA reductase inhibitors" type="drug"/><entity charOffset="227-235" id="DrugDDI.d12.s4.e3" origId="s4.p97" text="Fentanyl" type="drug"/><pair e1="DrugDDI.d12.s4.e0" e2="DrugDDI.d12.s4.e1" id="DrugDDI.d12.s4.p0" interaction="false"/><pair e1="DrugDDI.d12.s4.e0" e2="DrugDDI.d12.s4.e2" id="DrugDDI.d12.s4.p1" interaction="false"/><pair e1="DrugDDI.d12.s4.e0" e2="DrugDDI.d12.s4.e3" id="DrugDDI.d12.s4.p2" interaction="false"/><pair e1="DrugDDI.d12.s4.e1" e2="DrugDDI.d12.s4.e2" id="DrugDDI.d12.s4.p3" interaction="false"/><pair e1="DrugDDI.d12.s4.e1" e2="DrugDDI.d12.s4.e3" id="DrugDDI.d12.s4.p4" interaction="false"/><pair e1="DrugDDI.d12.s4.e2" e2="DrugDDI.d12.s4.e3" id="DrugDDI.d12.s4.p5" interaction="false"/></sentence><sentence id="DrugDDI.d12.s5" origId="s5" text="Drug-Laboratory Test Interactions: There are no reported drug-laboratory test interactions."><negationtags>Drug-Laboratory Test Interactions There are &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; reported drug-laboratory test interactions&lt;/xcope&gt;.</negationtags><negationtags>Drug-Laboratory Test Interactions: There are &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; reported drug-laboratory test interactions&lt;/xcope&gt;.</negationtags></sentence></document>